Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers

Eva Forgacs, Jonathan D. Wren, Craig Kamibayashi, Masashi Kondo, Xie L. Xu, Sanford Markowitz, Gail E. Tomlinson, Carolyn Y. Muller, Adi F. Gazdar, Harold R. Garner, John D. Minna

研究成果: Article

16 引用 (Scopus)

抜粋

RepX represents a new informatics approach to probe the UniGene database for potentially polymorphic repeat sequences in the open reading frame (ORF) of genes, 56% of which were found to be actually polymorphic. We now have performed mutational analysis of 17 such sites in genes not found to be polymorphic (<0.03 frequency) in a large panel of human cancer genomic DNAs derived from 31 lung, 21 breast, seven ovarian, 21 (13 microsatellite instability (MSI)+ and eight MSI-) colorectal cancer cell lines. In the lung, breast and ovarian tumor DNAs we found no mutations (<0.03-0.04 rate of tumor associated open reading frame mutations) in these sequences. By contrast, 18 MSI+ colorectal cancers (13 cancer cell lines and five primary tumors) with mismatch repair defects exhibited six mutations in three of the 17 genes (SREBP-2, TAN-1, GR6) (P<0.000003 compared to all other cancers tested). We conclude that coding region microsatellite alterations are rare in lung, breast, ovarian carcinomas and MSI (-) colorectal cancers, but are relatively frequent in MSI (+) colorectal cancers with mismatch repair deficits.

元の言語English
ページ(範囲)1005-1009
ページ数5
ジャーナルOncogene
20
発行部数8
DOI
出版物ステータスPublished - 22-02-2001
外部発表Yes

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

フィンガープリント Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Forgacs, E., Wren, J. D., Kamibayashi, C., Kondo, M., Xu, X. L., Markowitz, S., Tomlinson, G. E., Muller, C. Y., Gazdar, A. F., Garner, H. R., & Minna, J. D. (2001). Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers. Oncogene, 20(8), 1005-1009. https://doi.org/10.1038/sj.onc.1204211